Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation
Frontiers in Genetics · 21.08.2026 · 17
DOI: 10.3389/fgene.2026.1900298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 21.08.2026. Verfasst von Zhihong Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neutrophil extracellular trap-driven necrosis-related genes (NRGs) and inflammation-related genes (IRGs) are crucial in mitigating or inhibiting cancer progression in breast cancer patients. The interaction between NRGs and IRGs in breast cancer remains unclear. Thus, identifying prognostic genes associated with NETosis and inflammation in breast cancer may offer a novel approach to improving the outcome of breast cancer.
Methods
Genes with statistically significant expression levels and correlations with IRGs and NRGs scores were selected as candidate genes, and the protein-protein interactions of the encoded proteins were explored. Subsequently, prognostic genes were further identified and build the risk model. Lastly, independent prognostic factors were determined through independent prognostic analysis, a prognostic model was established, and the immune microenvironment and drug sensitivity were analyzed.
Results
The study identified ZMYND10 , IL12B , CXCL13 , TFF1 , LTB , and SPIB as prognostic genes. Additionally, risk score and three clinical features, including age, were established as independent prognostic factors. A prognostic model with moderate predictive accuracy was developed. Further analysis revealed that six prognostic genes were considerably correlated with differential immune cells, among which CXCL13 , IL12B , LTB , and SPIB were considerably positively correlated with most differential immune cells. Additionally, 18 drugs were considerably associated with the risk score, including six drugs such as Metformin and Thapsigargin, which could potentially be used to treat breast cancer.
Conclusion
This study constructed a risk model and a nomogram for breast cancer prognosis using bioinformatics methods, and analyzed prognostic genes of breast cancer, which will be helpful to the improvement of breast cancer’s outcome and the development of clinical medicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast Surgery, Nanchang People's Hospital, Nanchang, China.
Zitieren
APA
Xu, Z., Ma, Q., Jiang, Q., Wei, W., & Tao, D. (2026). Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1900298
Vancouver
Xu Z, Ma Q, Jiang Q, Wei W, Tao D. Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1900298
BibTeX
@article{Xu2026,
author = {Xu, Zhihong and Ma, Qian and Jiang, Qihua and Wei, Wensong and Tao, Dan},
title = {Identification of NETs and inflammation-related prognostic genes in breast cancer and PCR experimental validation},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1900298}
}
EUVIMED